Correction to: The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro‑entero‑pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu] Lu‑DOTATATE.

The article addresses a correction regarding the name of Dr. Enrico Matteo Garanzini, which was inaccurately presented in a previously published article. The correction clarifies that his name should be listed as Garanzini Enrico Matteo. This erratum serves to ensure the accuracy of authorship in th...

Full description

Bibliographic Details
Published in:European Journal of Nuclear Medicine & Molecular Imaging Vol. 52; no. 13; pp. 5208 - 5209
Main Authors: Maccauro, Marco, Cuomo, Mariarosaria, Bauckneht, Matteo, Bagnalasta, Matteo, Mazzaglia, Stefania, Scalorbi, Federica, Argiroffi, Giovanni, Kirienko, Margarita, Lorenzoni, Alice, Aliberti, Gianluca, Pusceddu, Sara, Giuseppina, Calareso, Garanzini, Enrico Matteo, Seregni, Ettore, Chiesa, Carlo
Format: Journal Article
Published: Springer Nature Nov2025
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=189136486&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 189136486
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        16197070
        NPC
      jtl: European Journal of Nuclear Medicine & Molecular Imaging
      issn: 16197070
      maglogo: N
    pubinfo:
      dt: Nov2025
      vid: 52
      iid: 13
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        189136486
        185721153
        10.1007/s00259-025-07378-w
        189136486
      ppf: 5208
      ppct: 1
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Correction to: The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro‑entero‑pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu] Lu‑DOTATATE.
      aug:
        au:
          Maccauro, Marco
          Cuomo, Mariarosaria
          Bauckneht, Matteo
          Bagnalasta, Matteo
          Mazzaglia, Stefania
          Scalorbi, Federica
          Argiroffi, Giovanni
          Kirienko, Margarita
          Lorenzoni, Alice
          Aliberti, Gianluca
          Pusceddu, Sara
          Giuseppina, Calareso
          Garanzini, Enrico Matteo
          Seregni, Ettore
          Chiesa, Carlo
        affil: https://ror.org/05dwj7825 Nuclear Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy
      sug:
      ab: The article addresses a correction regarding the name of Dr. Enrico Matteo Garanzini, which was inaccurately presented in a previously published article. The correction clarifies that his name should be listed as Garanzini Enrico Matteo. This erratum serves to ensure the accuracy of authorship in the academic record. The publisher, Springer Nature, maintains a neutral stance on jurisdictional claims related to published maps and institutional affiliations.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Unknown
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N